搜尋優化
Rewards
Deutsch
|
English
搜尋
Copilot
圖片
影片
地圖
新聞
購物
更多
航班
旅遊
旅館
我的 Bing
筆記本
Artikel des Tages
Welt
Deutschland
Wirtschaft
Unterhaltung
Sport
Sci-Tech
Bing 上的熱門主題
Schlafen im Elternbett
Wie wirkt das Salzspray?
Grimmiges Baby geht viral
Auf der Anklagebank
Sollte zur Pflicht werden
Unfall oder Sabotage?
Wie rechts ist die Elite?
China trifft USA
Sagt Boomern den Kampf an
Ist nicht die Einzige
Rekord-Galaxie entdeckt
'Das ist richtig krass'
Schutz vor Alzheimer
Stirbt bei Balkoneinsturz
Ist der falsche Weg
Muss er ins Gefängnis?
Die besten Deals
'Seit neun Jahren zölibatär'
'Gefährlicher Präzedenzfall'
Neuer Wärmerekord
Welche Fischarten meiden?
Macht sie uns krank?
Soll Ex gewürgt haben
Trauer um Let's Dance-Profi
Deutsche Waffen erlaubt!
Größtes Manöver beendet
Staatliche Desinformation
Politisches Motiv?
Bundesweite Aktionen
Hier drohen Bußgelder
Viel Zucker, viel Koffein
DWD: Höchste Warnstufe!
Muss Millionenstrafe zahlen
Dreht mit Ryan Gosling
過去 30 天
任何時間
過去 1 小時
過去 24 小時
過去 7 天
最符合項目
最近的新聞
13 天
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
(Reuters) -Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors ...
12 天
on MSN
Novavax top investor ends proxy fight after Sanofi deal
Shah Capital, a top shareholder of Novavax (NASDAQ:NVAX), has withdrawn its proxy campaign against the company days after the ...
23 天
on MSN
Novavax surges as Sanofi COVID vaccine deal boosts outlook
Novavax (NVAX) stock surged after reaching a licensing agreement with Sanofi (SNY) for its COVID-19 vaccine and Matrix-M adjuvant. Read more here.
13 天
Novavax investor drops proxy battle in wake of big pharma deal
A Novavax shareholder that had been waging a campaign to oust three board members at the Gaithersburg company has now ...
pharmaphorum
12 天
Novavax investor withdraws proxy fight after Sanofi deal
Shah Capital Management has withdrawn a proxy campaign against the re-election of directors at vaccines firm Novavax in the ...
21 天
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination ...
19 天
Novavax Stock Just Tripled. Is It Too Late to Buy?
Aventis S.A. ADR (SNY-Q) from The Globe and Mail including charting and trades.
devdiscourse
8 天
Novavax's Race to Update COVID Vaccine for U.S. Approval
2 variant. Novavax recently struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID vaccine, bolstering ...
20 天
Novavax Shares Pop Another 50% Following Sanofi Deal
By Ben Glickman Shares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with ...
15 天
Is Novavax Stock a Buy?
Novavax ( NVAX -9.65%) has been a highly volatile stock in recent years, and that volatility is on full display again this ...
Zacks.com on MSN
12 天
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Novavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company. This withdrawal is in ...
11 天
on MSN
Better Buy: Inovio Pharmaceuticals vs. Novavax
Novavax could receive up to $700 million in development milestone payments from this deal. The biotech will also earn ...
某些結果已隱藏,因為您可能無法存取這些結果。
顯示無法存取的結果
意見反應